Evidence Hub

Investigating the zoonotic origins of ESBL-producing E. coli in community-acquired urinary tract infections in Ecuador

Yashan Wang, Daniel E. Park, Maliha Aziz, Liseth Salinas, Edward H. Sung, Søren Hallstrøm, Cindy Meng-Hsin Liu, Marc Stegger et al.

Microbiology Spectrum, 2026

1 citation

Abstract

ABSTRACT Extended-spectrum β-lactamase-producing Escherichia coli (ESBL-producing E. coli ) pose a growing global health threat. Although Latin America has been identified as a global hotspot of antimicrobial resistance, the zoonotic contribution to drug-resistant infections in the region remains poorly defined. We analyzed 137 clinical ESBL-producing E. coli isolates from urinary tract infections (UTIs) in Quito, Ecuador, applying a Bayesian latent class model informed by host-associated mobile genetic elements to estimate the fraction of infections attributable to food-animal sources. We estimated that 25.5% (35/137) of UTI isolates were putative zoonotic cases. This proportion rose to 42.5% after excluding ST131- H 30, a human-associated pandemic lineage. Putative zoonotic isolates were enriched for animal-associated β-lactamase genes (e.g., bla TEM-1B , bla CTX-M-65 ), lacked human-associated markers such as bla OXA-1 , and exhibited diverse antimicrobial resistance gene profiles resembling those observed among food-animal isolates. These isolates were also enriched for ColV-associated virulence genes typically linked to avian pathogenic E. coli . Putative zoonotic strains contributed substantially to third-generation cephalosporin-resistant UTIs in Quito, Ecuador, challenging assumptions derived from high-income settings that such infections are driven predominantly by human-to-human transmission. These findings highlight the importance of integrated One Health…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free